What Preclinical Research Shows About 5-Amino-1MQ

At a Glance: The 5-Amino-1MQ Evidence Base

Preclinical evaluations identify 5-amino-1mq as a membrane-permeable, small-molecule inhibitor targeting the cytosolic enzyme nicotinamide N-methyltransferase (NNMT). By blocking NNMT activity, the compound prevents the irreversible methylation of nicotinamide, preserving the direct salvage pathway required for nicotinamide adenine dinucleotide (NAD+) synthesis.

In vitro assays and rodent models demonstrate that NNMT inhibition increases intracellular NAD+ availability, alters SAM/SAH methyl donor balances, and enhances mitochondrial respiration in metabolic tissues. Researchers investigate these mechanisms to evaluate cellular energy expenditure, lipid accumulation in adipocytes, and skeletal muscle metabolic resistance.

To maintain assay reproducibility across cellular and animal models, investigators require verified reference standards. PX1 Research provides fully characterized material accompanied by lot-specific analytical documentation, accessible through our complete catalog of research peptides.

How Does 5-Amino-1MQ Function as an NNMT Inhibitor?

Nicotinamide N-methyltransferase (NNMT) is a metabolic enzyme primarily expressed in adipose tissue, liver, and skeletal muscle. NNMT catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), generating 1-methylnicotinamide (1-MNA) and S-adenosylhomocysteine (SAH). Because 1-MNA is excreted or further oxidized, NNMT activity effectively drains the pool of NAM available for NAD+ regeneration via the NAD+ salvage pathway.

Molecular docking and kinetic studies indicate that 5 amino 1mq binds directly to the active site of NNMT as a substrate-competitive inhibitor. By reducing NNMT enzyme activity, the molecule limits 1-MNA production, thereby preserving intracellular NAM levels. This shift allows nicotinamide phosphoribosyltransferase (NAMPT) to convert NAM back into nicotinamide mononucleotide (NMN), ultimately driving NAD+ synthesis.

Furthermore, preclinical studies suggest that blocking NNMT alters cellular methylation potential. Because SAM serves as the primary methyl donor for DNA, RNA, and histone methyltransferases, NNMT overexpression acts as a methyl sink. Inhibiting this target with amino 1mq stabilizes the SAM/SAH ratio, allowing researchers to explore downstream epigenetic and transcriptional modifications in metabolic gene networks.

What Do 5-Amino-1MQ Research Studies Show Regarding Cellular Metabolism?

Published 5-amino-1mq research studies focus predominantly on tissue-specific metabolic regulation, particularly within white adipose tissue (WAT) and skeletal muscle cells. Overexpression of NNMT is strongly correlated with diet-induced metabolic dysfunction, altered adipocyte architecture, and reduced mitochondrial density in laboratory animal models.

In murine diet-induced obesity (DIO) models, administration of selective NNMT inhibitors demonstrated marked shifts in basal energy expenditure. In vitro data indicate that adipocytes treated with 5-Amino-1MQ exhibit increased basal oxygen consumption rates (OCR) without altering total nutrient intake in corresponding animal models. This suggests an uncoupling or upregulation of baseline mitochondrial respiration rather than appetite suppression.

When investigating fat-metabolism research models, scientists observe that NNMT inhibition reduces lipid droplet size in 3T3-L1 adipocyte cultures. These cellular changes coincide with an upregulation of genes associated with fatty acid oxidation (such as CPT-1a and PPAR-alpha) and a decrease in lipogenic gene expression (including FAS and ACC). Laboratories studying metabolic flux frequently pair this target with other pathways in the PX1 scientific research library.

How Does NNMT Inhibition Impact Intracellular NAD+ and Mitochondrial Output?

Intracellular NAD+ is a critical coenzyme for sirtuins (SIRT1-SIRT7) and poly(ADP-ribose) polymerases (PARPs), enzymes that regulate mitochondrial biogenesis, oxidative stress responses, and DNA repair. Preclinical models show that when NNMT activity is high, intracellular NAD+ pools drop significantly, compromising SIRT1 activation.

By applying 5-Amino-1MQ in cellular assays, researchers observed a concentration-dependent increase in salvage-derived NAD+. Elevated NAD+ stimulates SIRT1 enzymatic activity, which subsequently deacetylates peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1a). PGC-1a acts as the master regulator of mitochondrial biogenesis, triggering the expression of nuclear and mitochondrial genes required for oxidative phosphorylation.

Extracellular flux analysis (Seahorse assays) on treated skeletal muscle cells confirms an elevated mitochondrial reserve capacity. Research teams evaluating cellular energetics can source analytical-grade 5-Amino-1MQ 5mg vials to validate mitochondrial biogenesis markers including TFAM, NDUFS1, and ATP synthase subunits in vitro.

Key Preclinical Data: In Vitro Assays and Rodent Models

The preclinical literature surrounding 5-Amino-1MQ spans isolated enzymatic assays, immortalized cell lines, primary tissue explants, and rodent disease models. Below is a summary of observed parameters established across peer-reviewed literature:

1. Enzymatic Inhibition Kinetics: In cell-free assays, 5-Amino-1MQ exhibits a low micromolar inhibitory concentration (IC50 ~ 2.1 uM) against human recombinant NNMT, demonstrating high selectivity over related methyltransferases like INMT or PNMT.

2. Adipocyte Differentiation Assays: In 3T3-L1 cell cultures, exposure to the compound during differentiation resulted in a significant decrease in intracellular triglyceride content alongside elevated basal NAD+ concentrations.

3. High-Fat Diet Murine Models: Rodent models receiving high-fat diets supplemented with selective NNMT inhibitors demonstrated resistance to weight gain, reduced epididymal fat pad mass, and improved glucose clearance profiles compared to vehicle-treated controls.

4. Skeletal Muscle Myotubes: In C2C12 myotubes, treatment restored suppressed mitochondrial membrane potential under lipotoxic (palmitate-induced) conditions, confirming a protective bioenergetic effect in vitro.

Comparing Metabolic Research Targets in Laboratory Settings

When designing protocols for metabolic or bioenergetic research, investigators often evaluate 5-Amino-1MQ alongside other small molecules and peptides targeting mitochondrial function, incretin receptors, or NAD+ synthesis. Selecting the appropriate control or complementary compound depends on the specific primary endpoint.

Parameter: Primary Target 5-Amino-1MQ: Cytosolic NNMT enzyme inhibition MOTS-c: Mitochondrial-derived peptide (AMPK pathway) Retatrutide: Triple agonist (GIP/GLP-1/Glucagon receptors) NAD+ Precursors (e.g., NMN): Direct substrate provision for NAD+ salvage

Parameter: Cellular Mechanism 5-Amino-1MQ: Prevents NAM loss to elevate endogenous NAD+ salvage MOTS-c: Regulates nuclear gene expression and folate/purine metabolism Retatrutide: Activates GPCR signaling cascades to alter metabolic rate NAD+ Precursors: Increases substrate supply for NAMPT/NMNAT enzymes

Parameter: Primary In Vitro Endpoint 5-Amino-1MQ: SAM/SAH ratio, 1-MNA reduction, adipocyte lipid clearance MOTS-c: Glucose uptake, GLUT4 translocation, metabolic stress adaptation Retatrutide: cAMP accumulation, receptor internalization, insulin secretion NAD+ Precursors: Total intracellular NAD+/NADH ratios

To explore complementary targets, researchers can compare bioenergetic compounds like MOTS-c mitochondrial research vials or advanced incretin targets such as Retatrutide research peptides.

Evaluating Peptide Quality: How PX1 Research Benchmarks 5-Amino-1MQ

Interpreting metabolic data requires high chemical purity and consistency across experimental lots. Impurities in small-molecule inhibitors or peptides can induce off-target cytotoxicity, confound Seahorse flux readings, or cause unspecific cellular stress responses.

PX1 Research establishes rigid quality control parameters for every lot of 5-Amino-1MQ distributed to domestic and international academic institutions:

Purity Verification: High-Performance Liquid Chromatography (HPLC) confirms purity levels exceeding 98%. Chromatograms are provided with every order showing sharp target peaks free from residual synthetic intermediates.

Identity Confirmation: Mass Spectrometry (MS) verifies exact molecular weight and structural integrity, ensuring absolute batch-to-batch identity.

Endotoxin Quantification: Chromogenic LAL testing verifies bacterial endotoxin levels are strictly below acceptable thresholds for cell culture and preclinical administration.

Traceability & Documentation: Every individual vial is tied to a specific lot number matching an publicly available Certificate of Analysis (COA) directly downloadable from our portal.

Red Flags and How to Vet a Research Peptide Supplier

The market for research chemicals and small-molecule inhibitors contains significant variance in analytical rigor. Unverified vendors often distribute mislabeled, under-dosed, or contaminated compounds that ruin months of experimental trial work.

When vetting a vendor for laboratory reagents, verify these standard criteria:

1. Absence of Lot-Specific COAs: Avoid suppliers that provide static, generic analytical reports. COAs must display a recent analysis date, explicit lot number matching your vial, and raw analytical chromatograms rather than simple text summaries.

2. Domestic vs. Overseas Synthesis Transparency: Ensure the supplier clearly states their synthesis origins and maintains local quality control standards rather than re-shipping unverified bulk powder imports.

3. Lack of Endotoxin Testing: For in vitro cell culture, elevated endotoxin levels alter macrophage responses and alter cytokine profiles. If a supplier cannot present LAL endotoxin data, the material is unsuitable for precise bioenergetic research.

4. Ambiguous Licensing or Regulatory Disclaimers: Legitimate suppliers sell exclusively for laboratory research use and provide detailed technical specifications without making consumer health claims or offering administration advice.

Handling, Reconstitution, and Storage Protocols in Laboratory Settings

To ensure stability and maintain target potency during analytical testing, laboratories must handle 5-Amino-1MQ according to established chemical handling procedures.

5-Amino-1MQ is supplied in lyophilized or crystalline powder format. Lyophilized vials should be stored at -20°C upon receipt, shielded from ambient light and moisture. Unopened dry powder remains stable under freezer conditions for up to 24 months.

For reconstituted working solutions, researchers typically solubilize the compound in sterile dimethyl sulfoxide (DMSO) or ethanol, depending on assay tolerance, before diluting into aqueous buffer systems like phosphate-buffered saline (PBS). Reconstituted stock solutions should be aliquoted into single-use microcentrifuge tubes and stored at -80°C to avoid repeated freeze-thaw cycles, which degrade small-molecule activity.

For high-throughput screening or multi-plate assay projects, laboratories can coordinate custom stock allocations through our dedicated bulk research quantities program.

Ordering 5-Amino-1MQ from PX1 Research

PX1 Research serves as a trusted primary vendor for academic laboratories, biotechnology firms, and independent research institutions requiring analytical-grade small molecules and peptides.

When you buy order 5 mg vials of 5-Amino-1MQ from PX1 Research, your order ships in secure, temperature-monitored packaging. Orders finalized before 12:00 PM PST Monday through Friday dispatch same-day from our fulfillment facilities in California or Arizona, ensuring minimal transit times via tracked domestic carriers.

Every shipment includes full batch traceability, lot-specific COA documentation accessible online, and dedicated technical support available to assist with analytical specifications. Visit our storefront today to order high-purity 5-Amino-1MQ 5mg vials for your laboratory's ongoing metabolic studies.